Drawing for CANTON BIOLOGICS

USPTO serial 88513445

CANTON BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 6154612Status 701Renewal
Filing date
Status date
Registration date
Sep 15, 2020
Examiner
OPUTA, CHIOMA N
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with CANTON BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu APEX ATTORNEYS AT LAW, LLP160 ALAMO PLAZA #942ALAMO, CA 94507United States

Goods and services

ClassDescriptionStatusFirst use
001[ Proteins for use in the manufacture of food supplements; proteins for the food industry; ] protein for use in the manufacture of cosmetics; protein in raw material form for scientific and medical research; protein for industrial use; [ animal albumen for use in the manufacture of skin care product; animal albumen as a raw material for industrial use; diagnostic preparations other than for medical or veterinary purposes; ] biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of microorganisms, other than for medical and veterinary use; [ chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biochemical catalysts; stem cells, other than for medical or veterinary purposes ]ACTIVEFeb 20, 2019
005Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies; pharmaceuticals, namely, preparations for antibody and antibody-derivative development; pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders; cytokine preparations and antibodies in the nature of pharmaceutical preparations for the treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, namely, immuno- therapeutics and cytokines for the treatment of oncological and autoimmune diseases and disorders; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; medicines for the treatment of gastrointestinal diseases, for human purposes; pharmaceutical products for the prevention and treatment of cancer, for human purposes; tumor suppressing agents, for human purpose; [ pharmaceutical preparations for use in chemotherapy; ] pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; vaccines; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for treating cancer; nutritional supplements; biocides; surgical glues ]ACTIVEFeb 20, 2019
042Biological research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; biotechnology research; testing of pharmaceuticals; analysis of the mode of action of chemical combinations on animals; bacteriological research; scientific laboratory services; scientific research; biomedical research servicesACTIVEFeb 20, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Nov 17, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Nov 14, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 14, 2026ES8RTEAS SECTION 8 RECEIVED—
Sep 15, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 3, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 15, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 14, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 13, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 24, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 24, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 5, 2020IUAFUSE AMENDMENT FILED—
Jul 5, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 25, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 31, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2019DOCKASSIGNED TO EXAMINER—
Jul 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance